Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: SGLT2I, . Treffer: 14

2025

Muhs, T; Ljubojevic-Holzer, S; Sattler, S Anti-inflammatory Therapies for Ischemic Heart Disease.
Curr Cardiol Rep. 2025; 27(1): 57 Doi: 10.1007/s11886-025-02211-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Valenzuela, Ripoll, C; Lotfinaghsh, A; Guo, Z; Kumari, T; Miyata, KN; Sargazi, A; Ozcan, M; Diab, A; Ataran, A; Hajirezaei, H; Rashidi, O; Yu, W; Cho, Y; Kovacs, A; Weinheimer, C; Nigro, J; Cases, O; Kozyraki, R; Oscarsson, J; Esterline, R; Levi, M; Berger, JH; Schilling, JD; Apte, RS; Sardiello, M; Peikert, A; Kosiborod, M; Adamo, L; Lowenstein, C; Christoffersen, C; Cho, J; Javaheri, A Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans.
JACC Adv. 2025; 4(6 Pt 2):101839 Doi: 10.1016/j.jacadv.2025.101839
PubMed FullText FullText_MUG

 

2024

Aziz, F; Tripolt, NJ; Pferschy, PN; Scharnagl, H; Abdellatif, M; Oulhaj, A; Benedikt, M; Kolesnik, E; von, Lewinski, D; Sourij, H Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.
Cardiovasc Diabetol. 2024; 23(1): 145 Doi: 10.1186/s12933-024-02221-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Benedikt, M; Oulhaj, A; Rohrer, U; Manninger, M; Tripolt, NJ; Pferschy, PN; Aziz, F; Wallner, M; Kolesnik, E; Gwechenberger, M; Martinek, M; Nürnberg, M; Roithinger, FX; Steinwender, C; Widkal, J; Leiter, S; Zirlik, A; Stühlinger, M; Scherr, D; Sourij, H; von, Lewinski, D Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds.
NEJM Evid. 2024; 3(10):EVIDoa2400147 Doi: 10.1056/EVIDoa2400147
PubMed FullText FullText_MUG

 

Caravaca-Fontán, F; Stevens, K; Padrón, M; Huerta, A; Montomoli, M; Villa, J; González, F; Vega, C; López, Mendoza, M; Fernández, L; Shabaka, A; Rodríguez-Moreno, A; Martín-Gómez, A; Labrador, PJ; Molina, Andújar, A; Prados, Soler, MC; Martín-Penagos, L; Yerovi, E; Medina, Zahonero, L; De, La, Flor, JC; Mon, C; Ibernon, M; Rodríguez, Gómez, A; Miquel, R; Sierra, M; Mascarós, V; Luzardo, L; Papasotiriou, M; Arroyo, D; Verdalles, Ú; Martínez-Miguel, P; Ramírez-Guerrero, G; Pampa-Saico, S; Moral, Berrio, E; Canga, JLP; Tarragón, B; Fraile, Gómez, P; Regidor, D; Relea, J; Xipell, M; Andrades, Gómez, C; Navarro, M; Álvarez, Á; Rivas, B; Quintana, LF; Gutiérrez, E; Pérez-Valdivia, MÁ; Odler, B; Kronbichler, A; Geddes, C; Anders, HJ; Floege, J; Fernández-Juárez, G; Praga, M Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis.
Nephrol Dial Transplant. 2024; 39(2):328-340 Doi: 10.1093/ndt/gfad175
Web of Science PubMed FullText FullText_MUG

 

Halimi, JM; Sarafidis, P; Azizi, M; Bilo, G; Burkard, T; Bursztyn, M; Camafort, M; Chapman, N; Cottone, S; de, Backer, T; Deinum, J; Delmotte, P; Dorobantu, M; Doumas, M; Dusing, R; Duly-Bouhanick, B; Fauvel, JP; Fesler, P; Gaciong, Z; Gkaliagkousi, E; Gordin, D; Grassi, G; Grassos, C; Guerrot, D; Huart, J; Izzo, R; Jaén, Águila, F; Járai, Z; Kahan, T; Kantola, I; Kociánová, E; Limbourg, F; Lopez-Sublet, M; Mallamaci, F; Manolis, A; Marketou, M; Mayer, G; Mazza, A; MacIntyre, I; Mourad, JJ; Muiesan, ML; Nasr, E; Nilsson, P; Oliveras, A; Ormezzano, O; Paixão-Dias, V; Papadakis, I; Papadopoulos, D; Perl, S; Polónia, J; Pontremoli, R; Pucci, G; Robles, NR; Rubin, S; Ruilope, LM; Rump, LC; Saeed, S; Sanidas, E; Sarzani, R; Schmieder, R; Silhol, F; Sokolovic, S; Solbu, M; Soucek, M; Stergiou, G; Sudano, I; Tabbalat, R; Tengiz, I; Triantafyllidi, H; Tsioufis, K; Václavík, J; van, der, Giet, M; der, Niepen, PV; Veglio, F; Venzin, R; Viigimaa, M; Weber, T; Widimsky, J; Wuerzner, G; Zelveian, P; Zebekakis, P; Lueders, S; Persu, A; Kreutz, R; Vogt, L Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney.
Blood Press. 2024; 33(1):2368800 Doi: 10.1080/08037051.2024.2368800
Web of Science PubMed FullText FullText_MUG

 

Schwegel, N; Toferer, C; Zach, DK; Santner, V; Höller, V; Lugitsch, J; Wallner, M; Gollmer, J; Aziz, F; von, Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
J Clin Med. 2024; 13(19): Doi: 10.3390/jcm13195966 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sourij, C; Aziz, F; Tripolt, NJ; Siller-Matula, J; Pferschy, PN; Kolesnik, E; Wallner, M; Eyileten, C; Postula, M; Oulhaj, A; Sourij, H; von Lewinski, D; EMMY study group Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trial.
Hellenic J Cardiol. 2024; 75: 3-8. Doi: 10.1016/j.hjc.2023.05.007
Web of Science PubMed FullText FullText_MUG

 

2023

Aziz, F; Tripolt, NJ; Pferschy, PN; Kolesnik, E; Mangge, H; Curcic, P; Hermann, M; Meinitzer, A; von, Lewinski, D; Sourij, H, , EMMY, Investigators Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial.
Cardiovasc Diabetol. 2023; 22(1): 184 Doi: 10.1186/s12933-023-01920-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Osto, E; Bonacina, F; Pirillo, A; Norata, GD Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: From clinical evidence to molecular mechanisms.
Pharmacol Res. 2023; 188: 106667 Doi: 10.1016/j.phrs.2023.106667
Web of Science PubMed FullText FullText_MUG

 

von, Lewinski, D; Kolesnik, E; Aziz, F; Benedikt, M; Tripolt, NJ; Wallner, M; Pferschy, PN; von, Lewinski, F; Schwegel, N; Holman, RR; Oulhaj, A; Moertl, D; Siller-Matula, J; Sourij, H Timing of SGLT2i initiation after acute myocardial infarction.
Cardiovasc Diabetol. 2023; 22(1): 269 Doi: 10.1186/s12933-023-02000-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Wicik, Z; Nowak, A; Jarosz-Popek, J; Wolska, M; Eyileten, C; Siller-Matula, JM; von, Lewinski, D; Sourij, H; Filipiak, KJ; Postuła, M Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis.
Front Pharmacol. 2022; 13: 901340 Doi: 10.3389/fphar.2022.901340 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Hecking, M; Sharif, A; Eller, K; Jenssen, T Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics.
Transpl Int. 2021; 34(1):27-48 Doi: 10.1111/tri.13783 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

von, Lewinski, D; Benedikt, M; Tripolt, N; Wallner, M; Sourij, H; Kolesnik, E Can sodium-glucose cotransporter 2 inhibitors be beneficial in patients with acute myocardial infarction?
Kardiol Pol. 2021; 79(5):503-509 Doi: 10.33963/KP.15969 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum